Related by context. Frequent words. (Click for all words.) 68 analyst Jami Rubin 67 Joel Sendek 63 Geoffrey Porges 63 Jon LeCroy 60 analyst Larry Biegelsen 58 Navid Malik 57 analyst Ehud Gelblum 57 Funtleyder 57 Folotyn 56 Karl Heinz Koch 55 David Begleiter 55 PTK ZK 55 Seamus Fernandez 55 analyst Charles Grom 54 Bristol Myers BMY 54 economist Helen Kevans 54 Krystexxa 53 Joe Osha 53 analyst Peter Nesvold 53 Damien Conover 52 analyst Glenn Schorr 52 Relovair 52 analyst Doug Leggate 52 spokesman Tony Plohoros 52 Tobias Levkovich 52 analyst Heather Bellini 52 ONXX 52 Michael Linenberg 52 exenatide LAR 51 JP Morgan 51 bapineuzumab 51 analyst Brian Modoff 51 Chris Brendler 51 axitinib 51 analyst Maynard Um 51 Biogen IDEC 51 analyst Douglas Sipkin 51 analyst Moshe Orenbuch 51 iclaprim 51 Glen Yeung 51 Robert Breza 51 analyst Tony Wible 51 Fablyn 51 analyst Bill Pecoriello 50 analyst Nikos Theodosopoulos 50 amrubicin 50 Tracleer 50 Matthew Emmens 50 analyst Benjamin Reitzes 50 Leerink 50 Amevive 50 economist Michael Feroli 50 Xenoport 50 Adventrx 50 Zadaxin 50 Drew Matus 50 analyst Koji Endo 50 bosutinib 50 Patrick Walravens 49 analyst Matthew Borsch 49 taspoglutide 49 ocrelizumab 49 Bill Shope 49 Intermune 49 Revlimid 49 Exanta 49 Scott Mushkin 49 SAR# [004] 49 Abiel Reinhart 49 Antegren 49 Afrezza 48 analyst Peter Misek 48 Sipkin 48 John Heinbockel 48 Tanona 48 elotuzumab 48 Treanda 48 analyst Ben Reitzes 48 analyst Himanshu Patel 48 Idenix Pharmaceuticals 48 analyst Kevin Crissey 48 Jay Gelb 48 analyst Brent Thill 48 Steven Wieting 48 Nasdaq CELG 48 Westcomb Securities 48 ASA# 48 Daniel Brebner 48 Joe Greff 48 DepoMed 48 vorapaxar 48 Stephen Massocca managing 48 Oxigene 48 Kuvan 47 Amrita Sen 47 lasofoxifene 47 proteasome inhibitor 47 Advate 47 Eli Lilly LLY 47 analyst Matthew Fassler 47 economist Jan Hatzius